12/17
07:32 am
ino
Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035, Featuring Profiles of Halozyme, HNS, INOVIO Pharmaceuticals and Medical International Technology and PharmaJet [Yahoo! Finance]
High
Report
Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035, Featuring Profiles of Halozyme, HNS, INOVIO Pharmaceuticals and Medical International Technology and PharmaJet [Yahoo! Finance]
12/13
07:00 am
ino
INOVIO Announces Pricing of $30 Million Public Offering
High
Report
INOVIO Announces Pricing of $30 Million Public Offering
12/12
04:01 pm
ino
INOVIO Announces Proposed Public Offering
High
Report
INOVIO Announces Proposed Public Offering
12/3
01:50 pm
ino
Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer [Yahoo! Finance]
Low
Report
Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer [Yahoo! Finance]
12/3
08:13 am
ino
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial [Yahoo! Finance]
Medium
Report
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial [Yahoo! Finance]
12/3
08:00 am
ino
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
Medium
Report
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
11/29
04:02 pm
ino
INOVIO Reports Inducement Grant Under Inducement Plan
Low
Report
INOVIO Reports Inducement Grant Under Inducement Plan
11/18
01:06 pm
ino
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Low
Report
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
11/18
12:38 pm
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at HC Wainwright from $12.00 to $5.00. They now have a "neutral" rating on the stock.
Low
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at HC Wainwright from $12.00 to $5.00. They now have a "neutral" rating on the stock.
11/18
09:27 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $33.00 to $15.00. They now have an "outperform" rating on the stock.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $33.00 to $15.00. They now have an "outperform" rating on the stock.
11/16
09:10 am
ino
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) [Yahoo! Finance]
Medium
Report
Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) [Yahoo! Finance]
11/15
01:19 pm
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $7.00 to $6.00. They now have a "sector perform" rating on the stock.
Low
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $7.00 to $6.00. They now have a "sector perform" rating on the stock.
11/15
02:34 am
ino
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... [Yahoo! Finance]
High
Report
Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... [Yahoo! Finance]
11/14
09:30 pm
ino
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/14
04:06 pm
ino
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
11/14
04:05 pm
ino
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
High
Report
INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/13
08:00 am
ino
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
Medium
Report
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
11/6
04:05 pm
ino
INOVIO to Present at Upcoming Scientific Conferences
Low
Report
INOVIO to Present at Upcoming Scientific Conferences
11/6
08:00 am
ino
INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
Low
Report
INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
10/21
08:00 am
ino
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Medium
Report
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
10/4
11:58 am
ino
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $8.00 to $7.00. They now have a "sector perform" rating on the stock.
Medium
Report
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $8.00 to $7.00. They now have a "sector perform" rating on the stock.
10/2
04:15 pm
ino
INOVIO Reports Inducement Grants Under Inducement Plan
Low
Report
INOVIO Reports Inducement Grants Under Inducement Plan
10/1
08:00 am
ino
INOVIO to Present at Upcoming Scientific Conferences
Medium
Report
INOVIO to Present at Upcoming Scientific Conferences